Some GMO Basics

MICHAEL STEBBINS | August 20, 2019

article image
Discussions about genetically modified organisms or GMOs are all over the mainstream media and on Facebook, Twitter, and Instagram. Lots of people have strong opinions about them. Some support the technology, while others adamantly oppose them. But how much do people know about them.  Yes, certainly we have been modifying our food for thousands of years, and many of the crops we eat today, through various breeding methods, look much different than they did 50, 100, and 500 years ago. But GMOs are the product of a specific type of breeding method that was developed in the 1970s and 1980s and reached the marketplace starting in the 1990s. 25 years on the market. 40 years in R&D. When you think about it that way, this is not a new technology at all! Check out this breeding methods infographic from GMO Answers to learn a little bit more about the different ways that farmers, researchers, and plant scientists improve seeds and plants, from crossbreeding, to mutagenesis, to transgenesis.

Spotlight

Iverson Genetics

Iverson Genetics Diagnostics is helping lead the way in genetic testing to health care providers to promote early disease detection and to help physicians achieve optimal dosing of critical medications. Iverson's genetic tests will become the model for comprehensive disease detection and informed treatment, ushering in a new era of predictive, preventative and affordable health care.

OTHER ARTICLES
MEDICAL

Better Purification and Recovery in Bioprocessing

Article | August 2, 2021

In the downstream portion of any bioprocess, one must pick through the dross before one can seize the gold the biotherapeutic that the bioprocess was always meant to generate. Unfortunately, the dross is both voluminous and various. And the biotherapeutic gold, unlike real gold, is corruptible. That is, it can suffer structural damage and activity loss. When discarding the dross and collecting the gold, bioprocessors must be efficient and gentle. They must, to the extent possible, eliminate contaminants and organic debris while ensuring that biotherapeutics avoid aggregation-inducing stresses and retain their integrity during purification and recovery. Anything less compromises purity and reduces yield. To purify and recover biotherapeutics efficiently and gently, bioprocessors must avail themselves of the most appropriate tools and techniques. Here, we talk with several experts about which tools and techniques can help bioprocessors overcome persistent challenges. Some of these experts also touch on new approaches that can help bioprocessors address emerging challenges.

Read More
DIAGNOSTICS

Making Predictions by Digitizing Bioprocessing

Article | April 20, 2021

With advances in data analytics and machine learning, the move from descriptive and diagnostic analytics to predictive and prescriptive analytics and controls—allowing us to better forecast and understand what will happen and thus optimize process outcomes—is not only feasible but inevitable, according to Bonnie Shum, principal engineer, pharma technical innovation, technology & manufacturing sciences and technology at Genentech. “Well-trained artificial intelligence systems can help drive better decision making and how data is analyzed from drug discovery to process development and to manufacturing processes,” she says. Those advances, though, only really matter when they improve the lives of patients. That’s exactly what Shum expects. “The convergence of digital transformation and operational/processing changes will be critical for the facilities of the future and meeting the needs of our patients,” she continues. “Digital solutions may one day provide fully automated bioprocessing, eliminating manual intervention and enabling us to anticipate potential process deviations to prevent process failures, leading to real-time release and thus faster access for patients.” To turn Bioprocessing 4.0 into a production line for precision healthcare, real-time release and quickly manufacturing personalized medicines will be critical. Adding digitization and advanced analytics wherever possible will drive those improvements. In fact, many of these improvements, especially moving from descriptive to predictive bioprocessing, depend on more digitization.

Read More

Spotlight

Iverson Genetics

Iverson Genetics Diagnostics is helping lead the way in genetic testing to health care providers to promote early disease detection and to help physicians achieve optimal dosing of critical medications. Iverson's genetic tests will become the model for comprehensive disease detection and informed treatment, ushering in a new era of predictive, preventative and affordable health care.

Events